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PURPOSE: Surgical management of obstructive left colon cancer (OLCC) is
controversial. The objective is to report on postoperative and oncological outcomes of
the different surgical options in patients operated on for OLCC.
METHODS: From 2000-2015, 1500 patients were treated for OLCC in centers
members of the French Surgical Association. Colonic stent (n=271), supportive care
(n=5), palliative derivation (n=4) were excluded. Among 1220 remaining patients, 456
had primary diverting colostomy (PDC), 329 a segmental colectomy (SC), 246 a
Hartmann's procedure (HP) and 189 a subtotal colectomy (STC) as first-stage surgery.
Perioperative data and oncological outcomes were compared retrospectively.
RESULTS: There was no difference between the 4 groups regarding gender, age, BMI
and comorbidities. Postoperative mortality and morbidity were 4-27% (PDC), 6-47%
(SC), 9-55% (HP), 13-60% (STC), respectively (P=0.005). Among the 431 living
patients after PDC, 321 (70%) patients had their primary tumour removed. Cumulative
mortality and morbidity favoured PDC (7-39%) and SC (6-40%) compared to HP
(1-47%) and STC (13-50%) (P=0.04). At the end of follow-up definitive stoma rates
were 39% (HP), 24% (PDC), 10% (SC), and 8% (STC) (P<0.0001). Five-year overall
and disease-free survival was: SC (67-55%), PDC (54-48%), HP (54-37%) and STC
(48-49%). After multivariate analysis, SC and PDC were associated with better
prognosis compared to HP and STC.
CONCLUSION: In OLCC, SC and PDC are the two preferred options in patients with
good medical conditions. For patients with severe comorbidities PDC should be
recommended, reserving HP and STC for patients with colonic ischaemia or



































Publié sur Okina (http://okina.univ-angers.fr)
